↓ Skip to main content

Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity

Overview of attention for article published in Clinical Research in Cardiology, January 2012
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
13 Mendeley
Title
Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity
Published in
Clinical Research in Cardiology, January 2012
DOI 10.1007/s00392-011-0411-3
Pubmed ID
Authors

Thomas Gremmel, Karin Frühwirth, Christoph W. Kopp, Alexandra Kaider, Sabine Steiner, Tamam Bakchoul, Ulrich J. H. Sachs, Renate Koppensteiner, Simon Panzer

Abstract

The frequency of heparin-induced platelet antibodies (H/PF4 antibodies) following heparin exposure during percutaneous intervention with stent implantation is unknown. These antibodies may activate platelets and therefore contribute to high on-clopidogrel residual platelet reactivity (HRPR).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 46%
Student > Ph. D. Student 2 15%
Other 1 8%
Student > Doctoral Student 1 8%
Professor 1 8%
Other 2 15%
Readers by discipline Count As %
Medicine and Dentistry 7 54%
Immunology and Microbiology 2 15%
Biochemistry, Genetics and Molecular Biology 1 8%
Agricultural and Biological Sciences 1 8%
Unknown 2 15%